The interplay of neurotransmitters in Alzheimer's disease. (Q46793063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16273023%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

The interplay of neurotransmitters in Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16273023%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Paul T Francis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16273023%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16273023%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16273023%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16273023%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

6-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16273023%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

11 Suppl 18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16273023%20AND%20SRC:MED&resulttype=core&format=json

The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Synaptic plasticity in animal models of early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

The medial temporal lobe memory system

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Deciphering the molecular basis of memory failure in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

beta-Amyloid precursor protein isoforms show correlations with neurones but not with glia of demented subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Presynaptic cholinergic dysfunction in patients with dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Human memory and the cholinergic system. A relationship to aging?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014164

7 January 2021

10.1017/S1092852900014164

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16273023%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference